CHANG LINDA L 4
4 · OSIRIS THERAPEUTICS, INC. · Filed Feb 28, 2018
Insider Transaction Report
Form 4
CHANG LINDA L
Chief Financial Officer
Transactions
- Award
Incentive Stock Option (right to buy)
2018-02-26$8.92/sh+20,000$178,400→ 20,000 totalExercise: $8.92From: 2019-02-26Exp: 2028-02-25→ Common Stock (20,000 underlying)
Footnotes (1)
- [F1]5,000 shares underlying this option shall vest on each of February 26, 2019, February 26, 2020, February 26, 2021 and February 26, 2022, subject to Reporting Person's continued service through the applicable vesting date.